Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 367
5
Diseases
72
Unique genes
0.096
Avg. similarity score
Atrial septal defect
Most-connected disease (4 links)
Disease
Searched: Atrial septal defect
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Atrial septal defect
Congenital heart septal defect
Ventricular septal defect
renpenning syndrome
Bafopathy
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Atrial septal defect | 4 | 4 | 35 |
| Congenital heart septal defect | 3 | 3 | 18 |
| Ventricular septal defect | 2 | 2 | 42 |
| renpenning syndrome | 2 | 2 | 1 |
| Bafopathy | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| CITED2 | 3 / 5 | Atrial septal defect, Congenital heart septal defect, Ventricular septal defect |
| GATA4 | 3 / 5 | Atrial septal defect, Congenital heart septal defect, Ventricular septal defect |
| NKX2-5 | 3 / 5 | Atrial septal defect, Congenital heart septal defect, Ventricular septal defect |
| PQBP1 | 3 / 5 | Atrial septal defect, Congenital heart septal defect, renpenning syndrome |
| ACTL6A | 2 / 5 | Atrial septal defect, Bafopathy |
| BMP2 | 2 / 5 | Atrial septal defect, Ventricular septal defect |
| CUL9 | 2 / 5 | Atrial septal defect, Ventricular septal defect |
| EPO | 2 / 5 | Congenital heart septal defect, Ventricular septal defect |
| GATA6 | 2 / 5 | Atrial septal defect, Ventricular septal defect |
| HSPBAP1 | 2 / 5 | Atrial septal defect, Congenital heart septal defect |
| HUWE1 | 2 / 5 | Atrial septal defect, Ventricular septal defect |
| ISL1 | 2 / 5 | Atrial septal defect, Ventricular septal defect |
| MYH6 | 2 / 5 | Atrial septal defect, Congenital heart septal defect |
| PARP14 | 2 / 5 | Atrial septal defect, Congenital heart septal defect |
| PCSK5 | 2 / 5 | Congenital heart septal defect, Ventricular septal defect |
| ROBO1 | 2 / 5 | Atrial septal defect, Congenital heart septal defect |
| SALL4 | 2 / 5 | Congenital heart septal defect, Ventricular septal defect |
| SMARCA4 | 2 / 5 | Atrial septal defect, Ventricular septal defect |
| TBX20 | 2 / 5 | Atrial septal defect, Ventricular septal defect |
| TBX5 | 2 / 5 | Atrial septal defect, Ventricular septal defect |
| YES1 | 2 / 5 | Congenital heart septal defect, Ventricular septal defect |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Molecules associated with elastic fibres | Reactome | 5 / 38 | 21.9× | 2.89e-6 | 1.16e-4 ✓ sig. |
| Physiological factors | Reactome | 3 / 12 | 41.7× | 4.37e-5 | 1.11e-3 ✓ sig. |
| Striated Muscle Contraction | Reactome | 4 / 36 | 18.5× | 6.05e-5 | 1.45e-3 ✓ sig. |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | Reactome | 3 / 14 | 35.7× | 7.17e-5 | 1.66e-3 ✓ sig. |
| Proteoglycans in cancer | KEGG | 7 / 204 | 5.7× | 2.13e-4 | 3.99e-3 ✓ sig. |
| Hypertrophic cardiomyopathy | KEGG | 5 / 99 | 8.4× | 3.11e-4 | 5.41e-3 ✓ sig. |
| Dilated cardiomyopathy | KEGG | 5 / 105 | 7.9× | 4.08e-4 | 6.74e-3 ✓ sig. |
| Hepatocellular carcinoma | KEGG | 6 / 170 | 5.9× | 5.31e-4 | 8.25e-3 ✓ sig. |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | Reactome | 2 / 7 | 47.7× | 7.30e-4 | 1.06e-2 ✓ sig. |
| Signaling by SCF-KIT | Reactome | 3 / 37 | 13.5× | 1.39e-3 | 1.73e-2 ✓ sig. |
| Regulation of gene expression by Hypoxia-inducible Factor | Reactome | 2 / 11 | 30.3× | 1.88e-3 | 2.19e-2 ✓ sig. |
| MAPK signaling pathway | KEGG | 7 / 299 | 3.9× | 2.04e-3 | 2.31e-2 ✓ sig. |
| GP1b-IX-V activation signalling | Reactome | 2 / 12 | 27.8× | 2.25e-3 | 2.48e-2 ✓ sig. |
| Hippo signaling pathway | KEGG | 5 / 157 | 5.3× | 2.48e-3 | 2.67e-2 ✓ sig. |
| Cytoskeleton in muscle cells | KEGG | 6 / 232 | 4.3× | 2.63e-3 | 2.79e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| heart development | GO:0007507 | 17 / 273 | 16.2× | 2.52e-16 | 2.23e-13 ✓ sig. |
| outflow tract septum morphogenesis | GO:0003148 | 9 / 28 | 83.4× | 7.26e-16 | 5.87e-13 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 25 / 1,208 | 5.4× | 1.16e-12 | 5.20e-10 ✓ sig. |
| heart morphogenesis | GO:0003007 | 9 / 61 | 38.3× | 1.65e-12 | 7.17e-10 ✓ sig. |
| endocardial cushion development | GO:0003197 | 6 / 13 | 120× | 4.44e-12 | 1.76e-9 ✓ sig. |
| atrial septum morphogenesis | GO:0060413 | 6 / 13 | 120× | 4.44e-12 | 1.76e-9 ✓ sig. |
| positive regulation of DNA-templated transcription | GO:0045893 | 20 / 778 | 6.7× | 7.78e-12 | 2.93e-9 ✓ sig. |
| regulation of DNA-templated transcription | GO:0006355 | 26 / 1,454 | 4.6× | 9.79e-12 | 3.61e-9 ✓ sig. |
| aortic valve morphogenesis | GO:0003180 | 7 / 37 | 49.1× | 8.78e-11 | 2.60e-8 ✓ sig. |
| outflow tract morphogenesis | GO:0003151 | 8 / 63 | 33.0× | 1.06e-10 | 3.11e-8 ✓ sig. |
| pharyngeal system development | GO:0060037 | 6 / 21 | 74.2× | 1.37e-10 | 3.91e-8 ✓ sig. |
| skeletal system development | GO:0001501 | 10 / 151 | 17.2× | 3.07e-10 | 7.92e-8 ✓ sig. |
| atrioventricular canal development | GO:0036302 | 5 / 11 | 118× | 3.35e-10 | 8.54e-8 ✓ sig. |
| endocardial cushion formation | GO:0003272 | 5 / 12 | 108× | 5.72e-10 | 1.37e-7 ✓ sig. |
| negative regulation of transcription by RNA polymerase II | GO:0000122 | 20 / 1,002 | 5.2× | 6.98e-10 | 1.63e-7 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Atrial septal defect | Ventricular septal defect | 0.164 | 11 | 5.93e-21 | 1.18e-19 ✓ sig. |
| Atrial septal defect | Congenital heart septal defect | 0.174 | 8 | 1.30e-17 | 2.18e-16 ✓ sig. |
| Congenital heart septal defect | Ventricular septal defect | 0.130 | 7 | 2.07e-14 | 2.83e-13 ✓ sig. |
| Congenital heart septal defect | renpenning syndrome | 0.053 | 1 | 1.17e-3 | 1.89e-3 ✓ sig. |
| Atrial septal defect | Bafopathy | 0.028 | 1 | 2.27e-3 | 3.19e-3 ✓ sig. |
| Atrial septal defect | renpenning syndrome | 0.028 | 1 | 2.27e-3 | 3.19e-3 ✓ sig. |